Funding for this research was provided by:
KWF Kankerbestrijding (IKNL 2015-7914)
Received: 8 April 2020
Accepted: 12 May 2020
First Online: 20 May 2020
Ethics approval and consent to participate
: The medical ethics committee region Arnhem-Nijmegen (Dutch: Commissie Mensgebonden onderzoek) reviewed the study protocol and determined that the BlaZIB study is beyond the scope of the Medical Research Involving Human Subjects Act (WMO). Participation in BlaZIB does not change standard of care and lays only a small extra burden on patients, e.g. filling in questionnaires. Therefore no further ethics approval is needed.All patients participating in the HRQL data collection gave written informed consent.
: Not applicable.
: The authors declare that they have no conflicts of interest.